HeartBeam Inc. (BEAT)
NASDAQ (CM) NASDAQ (CM) Primary Summary
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System
HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.
HeartBeam, Inc. (BEAT) Q3 2025 Earnings Call Transcript
HeartBeam, Inc. ( BEAT ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Robert Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conference Call Participants Kyle Bauser - ROTH Capital Partners, LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Presentation Operator Greetings, and welcome to the HeartBeam Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
HeartBeam, Inc. (BEAT) Q2 2025 Earnings Call Transcript
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ian Scargill - Corporate Participant Robert P. Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conference Call Participants William Sutherland - The Benchmark Company, LLC, Research Division Operator Greetings, and welcome to the HeartBeam Second Quarter 2025 Financial Results Conference Call.
HeartBeam Inc. (BEAT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has HeartBeam Inc. ever had a stock split?
HeartBeam Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Branislav Vajdic CEO | NASDAQ (CM) Exchange | 42238H108 CUSIP |
| US Country | 15 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
HeartBeam, Inc. is a pioneering medical technology company that was founded in 2015 and is headquartered in Santa Clara, California. The company specializes in the development and commercialization of advanced ambulatory electrocardiogram (ECG) solutions designed for both in-hospital and remote patient monitoring environments. HeartBeam's mission is centered on enhancing the detection and ongoing monitoring of cardiac diseases through the use of innovative technologies that provide detailed insights into cardiac electrical activity. By focusing on creating more accessible and effective diagnostic tools, HeartBeam, Inc. aims to significantly improve patient outcomes and transform the approach to cardiac care.
Products and Services
- Three-Dimensional Vector ECG Imaging
HeartBeam has pioneered the development of technology capable of generating three-dimensional vector images of the heart's electrical activity. This revolutionary approach offers a more comprehensive understanding of cardiac function and abnormalities, enabling healthcare providers to make more informed decisions regarding diagnosis and treatment.
- HeartBeam AIMIGo
HeartBeam AIMIGo represents a significant innovation in heart attack detection technology. It is a cloud-based diagnostic software system, compact enough to be the size of a credit card, designed for rapid and accurate heart attack detection outside the conventional hospital setting. This product aims to deliver immediate diagnostic capabilities to patients, potentially saving lives by enabling faster response times in critical situations.
